Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study.

Chin KM, Badesch DB, Robbins IM, Tapson VF, Palevsky HI, Kim NH, Kawut SM, Frost A, Benton WW, Lemarie JC, Bodin F, Rubin LJ, McLaughlin V
Am Heart J. 2014 167 (2): 218-225.e1

PMID: 24439983 · DOI:10.1016/j.ahj.2013.08.008

MeSH Terms (19)

Adolescent Adult Aged Antihypertensive Agents Dose-Response Relationship, Drug Epoprostenol Exercise Tolerance Familial Primary Pulmonary Hypertension Female Follow-Up Studies Hemodynamics Humans Hypertension, Pulmonary Injections, Intravenous Male Middle Aged Prospective Studies Treatment Outcome Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: